The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.
Saved in:
| Title: | The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen. |
|---|---|
| Authors: | Malta TM; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Sabedot TS; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan., Morosini NS; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan., Datta I; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan., Garofano L; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Vallentgoed W; Neurology Department, The Brain Tumour Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Varn FS; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Aldape K; National Cancer Institute, Bethesda, Maryland., D'Angelo F; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.; Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida., Bakas S; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Barnholtz-Sloan JS; National Cancer Institute, Bethesda, Maryland., Gan HK; Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Melbourne, Australia., Hasanain M; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Hau AC; Luxembourg Institute of Health, Luxembourg, Luxembourg., Johnson KC; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut., Cazacu S; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan., deCarvalho AC; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan., Khasraw M; Duke University, Durham, North Carolina., Kocakavuk E; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), National Center for Tumor Diseases (NCT) West, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Kouwenhoven MCM; Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Migliozzi S; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Niclou SP; Luxembourg Institute of Health, Luxembourg, Luxembourg., Niers JM; Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Ormond DR; University of Colorado School of Medicine, Department of Neurosurgery, Aurora, Colorado., Paek SH; Department of Neurosurgery, Cancer Research Institute, Hypoxia Ischemia Disease Institute, Seoul National University, Seoul, Republic of Korea (South)., Reifenberger G; Institute of Neuropathology, Heinrich Heine University, Dusseldorf, Germany., Sillevis Smitt PA; Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; The Brain Tumour Centre, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands., Stead LF; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom., van den Bent MJ; Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; The Brain Tumour Centre, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Van Meir EG; Department of Neurosurgery and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama., Walenkamp A; University of Groningen, Groningen, the Netherlands., Weiss T; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Westerman BA; Department of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Wesseling P; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Brain Tumor Center Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.; Laboratory for Childhood Cancer Pathology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lasorella A; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida., French PJ; Neurology Department, The Brain Tumour Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Poisson LM; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan., Verhaak RGW; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut.; Department of Neurosurgery, Amsterdam University Medical Center, Amsterdam, the Netherlands., Iavarone A; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.; Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida., Noushmehr H; Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan. |
| Corporate Authors: | Consortium The GLASS |
| Source: | Cancer research [Cancer Res] 2024 Mar 04; Vol. 84 (5), pp. 741-756. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
